We are live on ! Find out more
CMRAW

Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW

Delisted

CMRAW was delisted on the 15th of November, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $615 → $0 (-$615)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
LP
LMR Partners
United Kingdom
-$300
2
RCM
Rivernorth Capital Management
Florida
-$225
3
CS
Clear Street
New York
-$90
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
– -$300 -100,000 Closed
RCM
2
Rivernorth Capital Management
Florida
– -$225 -74,999 Closed
CS
3
Clear Street
New York
– -$90 -30,100 Closed

CMRAW Hedge Fund Activity: Q1 2024 in Review

0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) for Q1 2024, worth a combined $0 — down 100% from $615 a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CMRAW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was LMR Partners, exiting entirely with an estimated $300 sold.

  • 0 institutional investors held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) as of Q1 2024, down from 3 in Q4 2023.
  • Funds reported $0 of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 positions in Q1 2024 and 3 closed out, a net change of -3 holders.
  • The largest Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 seller in Q1 2024 was LMR Partners, an estimated $300 sold.

Based on aggregated 13F filings for Q1 2024.